Inhibition of in-vitro growth of Plasmodium falciparum by Pseudocedrela kotschyi extract alone and in combination with Fagara zanthoxyloides extract

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 7, 2009, Pages 698-702

  Kassim, Olakunle O ^a   Loyevsky, Mark ^a   Amonoo, Henrietta ^a   Lashley, Liesel ^a   Ako Nai, Kwashie A ^b   Gordeuk, Victor R ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

50 inhibitory concentration; Fagara zanthoxyloides; Plasmodium falciparum; Pseudocedrela kotschyi; Schizonts; Trophozoites

Indexed keywords

FAGARA ZANTHOXYLOIDES EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PSEUDOCEDRELA KOTSCHYI EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE TECHNIQUE; DRUG POTENTIATION; ERYTHROCYTE; FAGARA ZANTHOXYLOIDES; GROWTH INHIBITION; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; PLASMODIUM FALCIPARUM; PSEUDOCEDRELA KOTSCHYI; SCHIZONT;

ANIMALS; LIFE CYCLE STAGES; PARASITIC SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLASMODIUM FALCIPARUM; ZANTHOXYLUM;

FAGARA ZANTHOXYLOIDES; PLASMODIUM FALCIPARUM; PSEUDOCEDRELA; PSEUDOCEDRELA KOTSCHYI;

EID: 67349151305     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.02.018     Document Type: Article

References (16)

1. Trape J.F., Pison G., Spiegel A., Enel C., and Rogier C. Combating malaria in Africa. Trends Parasitol 18 (2002) 224-230
2. Trape J.F. The public health impact of chloroquine resistance in Africa. Am J Trop Med 64 (2001) 12-17
3. WHO. Antimalarial drug combination therapy. Report of a Technical Consultation (2001), World Health Organization, Geneva WHO/CDS/RBM/2001.35
4. Snow R.W., Eckert E., and Teklehaimanot A. Esimating the needs for artesunate-based combination therapy for malaria case-management in Africa. Trends Parasitol 19 (2003) 363-369
5. Onwujekwe O., Uzochukwu B., Shu E., Ibeh C., and Okonkwo P. Is combination therapy for malaria based on user-fees worthwhile and equitable to consumers? Assessment of costs and willingness to pay in Southeast Nigeria. Acta Trop 91 (2004) 101-115
6. Quattara B., Angenot L., Guissou P., Fondu P., Dubois J., Frederich M., et al. LC/MS/NMR analysis of isomeric divanilloylquinic acids from the root bark of Fagara zanyhoxyloides Lam. Phytochem 65 (2004) 1145-1151
7. Sofowora E., Isaacs W., and Ogunkoya L. Isolation and characterization of an antisickling agent from Fagara zanthoxyloides root. Lloydia 38 (1975) 169-171
8. Kassim O.O., Loyevsky M., Elliott B., Geall A., Amonoo H., and Gordeuk V.R. Effects of root extracts of Fagara zanthoxyloides on the in vitro growth and stage distribution of Plasmodium falciparum. Antimicrob Agents Chemother 49 (2005) 264-268
9. Trager W., and Jensen J. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
10. Loyevsky M., Lytton S., Mester B., Libman J., Shanzer A., and Cabantchik Z.I. The antimalarial action of desferal involves direct access route to erythrocytic (Plasmodium falciparum) parasites. J Clin Invest 91 (1993) 218-224
11. Berenbaum M.C. Criteria for analyzing interactions between biologically active agents. Adv Cancer Res 35 (1981) 269-335
12. Golab J., Nowis D., Skrzycki M., Czeczot H., Baranczyk-Kuzma A., Kopec M., et al. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol: a superoxide dismutase inhibitor. J Biol Chem 278 (2003) 407-414
13. Nakornchai S., and Konthiang P. Potentiation of antimalarial drug action by chlorpheniramine against multidrug resistant Plasmodium falciparum in vitro. Parasitol Int 55 (2006) 195-199
14. Azas N., Laurencin N., Delmas F., Di G.C., Gasquet M., Laget M., et al. Synergistic in vitro antimalarial activity of plant extracts used as traditional remedies in Mali. Parasitol Res 88 (2002) 165-171
15. Messmer W.M., Tin-Wa M., Fong H.H.S., Bevelle C., Farnsworth N.R., Abraham D.J., et al. Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam, (Rutaceae). J Pharm Sci 61 (1972) 1858-1859
16. Larsen A.K., Grondard L., Couprie J., Desoize B., Comor L., Jardillier J.C., et al. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem Pharmacol 46 (1993) 1403-1412